Kim Forest Enterprise Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 29, 2022 at 12:37 am
Share
Kim Forest Enterprise Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 600.67 million compared to TWD 302.9 million a year ago. Net income was TWD 89.44 million compared to net loss of TWD 26.15 million a year ago. Basic earnings per share from continuing operations was TWD 2.2231 compared to basic loss per share from continuing operations of TWD 0.7462 a year ago. Diluted earnings per share from continuing operations was TWD 2.1846 compared to diluted loss per share from continuing operations of TWD 0.7462 a year ago.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.